Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 19,299 | 33,089 | 34,135 | 34,653 | 32,684 |
| Operating Income | -19,299 | -33,089 | -34,135 | -34,653 | -32,684 |
| Other Income | 2,241 | 2,356 | 2,217 | 1,713 | 1,121 |
| Pre-tax Income | -17,058 | -30,733 | -31,918 | -32,940 | -31,563 |
| Net Income Continuous | -17,058 | -30,733 | -31,918 | -32,940 | -31,563 |
| Net Income | $-17,058 | $-30,733 | $-31,918 | $-32,940 | $-31,563 |
| EPS Basic Total Ops | -0.36 | -0.65 | -0.68 | -0.73 | -0.71 |
| EPS Basic Continuous Ops | -0.36 | -0.65 | -0.68 | -0.73 | -0.71 |
| EPS Diluted Total Ops | -0.36 | -0.65 | -0.68 | -0.73 | -0.71 |
| EPS Diluted Continuous Ops | -0.36 | -0.65 | -0.68 | -0.73 | -0.71 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.65 | -0.68 | -0.73 | -0.72 |
| EBITDA(a) | $-20,286 | $-34,231 | $-35,073 | $-35,194 | $-32,784 |